Table 2.
REGγ expression in human breast tissue and metastatic axillary lymph node
| REGγ expression | ||||||
|---|---|---|---|---|---|---|
|
|
||||||
| Case | Neg. | Low | High | Positive % | P-value | |
| Benign disease | 140 | 131 | 9 | 0 | 6.4% | |
| 0.008 | ||||||
| Normal breast | 136 | 136 | 0 | 0 | 0% | |
| < 0.001 | ||||||
| Breast cancer | 136 | 25 | 52 | 59 | 81.6% | |
| < 0.001 | ||||||
| Metastatic ALN | 116 | 0 | 29 | 87 | 100% | |
ALN, axillary lymph node. REGγ expression in breast benign disease tissue was significantly higher than normal breast (P = 0.008). REGγ expression in breast cancer was significantly higher than normal breast tissues (P < 0.001) and lower than metastatic ALN (P < 0.001).